Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Althoff

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Klinische Wochenschrift|December 15, 1981
[Bromocriptine in patients with idiopathic edema (author's transl)]E Jungmann, P H Althoff, U Schwedes, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1978
[Long-term treatment of acromegaly with bromocriptin--results and experiences after 3 years of therapy]P H Althoff, M Neubauer, B Böttger, et al.
Deutsche Medizinische Wochenschrift (1946)|March 16, 1979
[Characterisation of activity of a biphasic monocomponent insulin (author's transl)]M Neubauer, P H Althoff, O Schnabel, et al.
Klinische Wochenschrift|January 15, 1987
[Plasma renin activity and aldosterone behavior in critically ill patients]E Jungmann, E Schifferdecker, A Rümelin, et al.
Zeitschrift Fur Rheumatologie|November 1, 1980
[Glucosteroid activity in hyperthermia: an investigation of thermotherapy in rheumatology]M Bühring, C Rosak, F Schulz, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1986
Evidence for increased endogenous dopaminergic inhibition of aldosterone secretion in prolactinomaE Jungmann, U Schwedes, P H Althoff, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1986
Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronismE Jungmann, P H Althoff, C Rosak, et al.
Arzneimittel-Forschung|February 1, 1988
Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapyE Jungmann, T Haak, P H Althoff, et al.
Acta Endocrinologica|September 1, 1991
Effect of bromocriptine withdrawal in acromegaly on body composition as assessed by bioelectrical impedance analysisH Rau, H Fischer, K Schmidt, et al.
Clinical Neuropathology|March 1, 1993
Pituitary adenomas: serum hormone levels and immunohistochemical staining for ACTH, GH and prolactinT Herzog, W Schlote, R Lorenz, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Klinische Wochenschrift|December 15, 1981
[Bromocriptine in patients with idiopathic edema (author's transl)]E Jungmann, P H Althoff, U Schwedes, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1978
[Long-term treatment of acromegaly with bromocriptin--results and experiences after 3 years of therapy]P H Althoff, M Neubauer, B Böttger, et al.
Deutsche Medizinische Wochenschrift (1946)|March 16, 1979
[Characterisation of activity of a biphasic monocomponent insulin (author's transl)]M Neubauer, P H Althoff, O Schnabel, et al.
Klinische Wochenschrift|January 15, 1987
[Plasma renin activity and aldosterone behavior in critically ill patients]E Jungmann, E Schifferdecker, A Rümelin, et al.
Zeitschrift Fur Rheumatologie|November 1, 1980
[Glucosteroid activity in hyperthermia: an investigation of thermotherapy in rheumatology]M Bühring, C Rosak, F Schulz, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1986
Evidence for increased endogenous dopaminergic inhibition of aldosterone secretion in prolactinomaE Jungmann, U Schwedes, P H Althoff, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1986
Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronismE Jungmann, P H Althoff, C Rosak, et al.
Arzneimittel-Forschung|February 1, 1988
Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapyE Jungmann, T Haak, P H Althoff, et al.
Acta Endocrinologica|September 1, 1991
Effect of bromocriptine withdrawal in acromegaly on body composition as assessed by bioelectrical impedance analysisH Rau, H Fischer, K Schmidt, et al.
Clinical Neuropathology|March 1, 1993
Pituitary adenomas: serum hormone levels and immunohistochemical staining for ACTH, GH and prolactinT Herzog, W Schlote, R Lorenz, et al.
Pageof 8